FAQ/Help |
Calendar |
Search |
Today's Posts |
06-07-2020, 08:42 PM | #1 | ||
|
|||
Member
|
We haven't heard much on the research on lowering alpha synuclein to help Parkinson's. Or has this been found to be another dead end?
|
||
Reply With Quote |
06-07-2020, 10:19 PM | #2 | |||
|
||||
Grand Magnate
|
This is the most recent review on this that I can find.
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
__________________
Knowledge is power. |
|||
Reply With Quote |
"Thanks for this!" says: | parkinsons here-now (07-27-2020) |
07-27-2020, 05:27 AM | #3 | |||
|
||||
Junior Member
|
The battle against alpha-synuclein is back. Between 2000 and 2003 many interesting studies were conducted.
Magnesium and green tea have already been shown to prevent the addition of alpha-synuclein, the spontaneous one and that produced by iron (Golts 2002, Xu 2016). Could the elevated level of homocysteine in the blood and in the brain - it crosses its protective barrier - be responsible for the alteration of alpha-synuclein? (Enomoto 2019). This would add vitamins B6, B9 and B12 to the arsenal against alpha-synuclein, acting against homocysteine (the latter as recommended by Dr. Ahlskog in his books). Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein - PubMed Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease - PubMed https://aanddjournal.net/article/S15...853-2/fulltext |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||